Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6292-59-7

Post Buying Request

6292-59-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6292-59-7 Usage

Description

4-tert-Butylbenzenesulfonamide is an organic compound that serves as an intermediate and a degradation impurity in the synthesis of the endothelin receptor antagonist Bosentan (B675900). It is characterized by its white solid appearance and is utilized in the pharmaceutical industry for the development and production of certain medications.

Uses

Used in Pharmaceutical Industry:
4-tert-Butylbenzenesulfonamide is used as an intermediate in the synthesis of Bosentan, a medication that acts as an endothelin receptor antagonist. It is particularly effective in treating pulmonary arterial hypertension and digital ulcers associated with systemic sclerosis.
Additionally, as a degradation impurity, 4-tert-Butylbenzenesulfonamide plays a role in the stability and quality control of Bosentan, ensuring the drug's efficacy and safety for patients.

Check Digit Verification of cas no

The CAS Registry Mumber 6292-59-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,9 and 2 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 6292-59:
(6*6)+(5*2)+(4*9)+(3*2)+(2*5)+(1*9)=107
107 % 10 = 7
So 6292-59-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO2S/c1-10(2,3)8-4-6-9(7-5-8)14(11,12)13/h4-7H,1-3H3,(H2,11,12,13)

6292-59-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • USP

  • (1076160)  Bosentan Related Compound E  United States Pharmacopeia (USP) Reference Standard

  • 6292-59-7

  • 1076160-15MG

  • 14,578.20CNY

  • Detail

6292-59-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Tert-Butylbenzenesulfonamide

1.2 Other means of identification

Product number -
Other names 4-Tert-butylbenzenesulfonamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6292-59-7 SDS

6292-59-7Synthetic route

4-tert-butylbenzenesulfonyl chloride
15084-51-2

4-tert-butylbenzenesulfonyl chloride

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With ammonium hydroxide for 72h; Ambient temperature;99%
With ammonium hydroxide In ethyl acetate at 20℃; for 1h;95%
With ammonium hydroxide In acetone at 20℃;94%
4,N-di-tert-butyl-benzenesulfonamide

4,N-di-tert-butyl-benzenesulfonamide

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With scandium tris(trifluoromethanesulfonate) In nitromethane at 50℃; for 5h;96%
4-tert-Butyl-N-isopropyl-benzenesulfonamide
5636-16-8

4-tert-Butyl-N-isopropyl-benzenesulfonamide

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With chromium(III) acetate hydroxide; periodic acid In acetonitrile at 20℃; for 14h;94%
(4-tert-butylphenyl)diazonium tetrafluoroborate
52436-75-6

(4-tert-butylphenyl)diazonium tetrafluoroborate

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With sodium metabisulfite; sodium azide; tetrabutylammomium bromide; triphenylphosphine In water; acetonitrile at 80℃; for 12h; Inert atmosphere;84%
With sodium metabisulfite; sodium azide; tetrabutylammomium bromide; triphenylphosphine In water; acetonitrile at 80℃; for 12h; Inert atmosphere; Schlenk technique;84%
4-(tert-butyl)-N,N-diethylbenzenesulfonamide

4-(tert-butyl)-N,N-diethylbenzenesulfonamide

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With chromium(III) acetate hydroxide; periodic acid In acetonitrile at 20℃; for 16h;81%
4-t-butylbenzenethiol
2396-68-1

4-t-butylbenzenethiol

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With [bis(acetoxy)iodo]benzene; ammonium carbamate In methanol at 25℃; for 24h; Inert atmosphere; chemoselective reaction;80%
potassium tert-butyltrifluoroboranuide

potassium tert-butyltrifluoroboranuide

4-bromo-benzenesulfonic acid amide
701-34-8

4-bromo-benzenesulfonic acid amide

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With dipotassium hydrogenphosphate; nickel(II) bis(2,2,6,6-tetramethylheptane-3,5-dionate); Ir(dF(CF3)ppy)2(bpy)PF6; zinc dibromide In N,N-dimethyl acetamide at 27℃; for 72h; Inert atmosphere; Irradiation;44%
1-tert-butyl-benzene-sulfonyl chloride-(4)

1-tert-butyl-benzene-sulfonyl chloride-(4)

ammonium carbonate

ammonium carbonate

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

tert-butylbenzene
253185-03-4, 253185-04-5

tert-butylbenzene

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: chlorosulfonic acid / 6 h / Reflux
2: ethanol / 1 h / 0 °C
View Scheme
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
150728-13-5

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide
150727-06-3

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide

Conditions
ConditionsYield
Stage #1: 4-tert-butylbenzenesulphonamide; 4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine With potassium carbonate In acetonitrile at 25 - 83℃; Large scale reaction;
Stage #2: Large scale reaction;
100%
With potassium carbonate In dimethyl sulfoxide at 100 - 105℃;100%
Stage #1: 4-tert-butylbenzenesulphonamide With potassium carbonate In toluene at 50℃; for 0.5h; Large scale;
Stage #2: 4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine With tetrabutylammomium bromide In toluene at 110℃; for 10h; Large scale;
97%
4-(2-tert-butoxyethoxy)-5-(2-methoxyphenoxy)-6-chloro-2,2'-bipyrimidine
1177447-87-8

4-(2-tert-butoxyethoxy)-5-(2-methoxyphenoxy)-6-chloro-2,2'-bipyrimidine

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

N-[6-[2-(1,1-dimethylethoxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide

N-[6-[2-(1,1-dimethylethoxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 120℃; for 10h;100%
4-methoxyphenethyl bromide
14425-64-0

4-methoxyphenethyl bromide

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

C19H22O3S

C19H22O3S

Conditions
ConditionsYield
With aluminum (III) chloride; trifluorormethanesulfonic acid; niobium pentachloride; bis-[(trifluoroacetoxy)iodo]benzene; zinc(II) iodide In N,N-dimethyl acetamide at 75℃; for 2.5h; Solvent; Reagent/catalyst;97.3%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-tert-butylbenzenesulfonamide monosodium salt

4-tert-butylbenzenesulfonamide monosodium salt

Conditions
ConditionsYield
With sodium ethanolate for 2h; Heating;97%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

C15H11ClN4O3
1268612-27-6

C15H11ClN4O3

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide
150727-06-3

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide

Conditions
ConditionsYield
Stage #1: 4-tert-butylbenzenesulphonamide With potassium carbonate In toluene at 50℃; for 0.5h; Large scale;
Stage #2: C15H11ClN4O3 In toluene at 110℃; for 10h; Large scale;
97%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
150728-13-5

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine

4-tert-butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzene sulfonamide potassium salt

4-tert-butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzene sulfonamide potassium salt

Conditions
ConditionsYield
Stage #1: 4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine With potassium carbonate for 0.25h;
Stage #2: 4-tert-butylbenzenesulphonamide at 140℃; for 3h; Solvent; Temperature; Time;
96.2%
Stage #1: 4-tert-butylbenzenesulphonamide With potassium hydroxide In acetone at 30℃; for 0.0833333h;
Stage #2: 4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine In acetone at 30℃; for 6.5h; Product distribution / selectivity; Reflux;
89%
With tetrabutylammomium bromide; potassium carbonate In toluene for 10h; Reflux;87.7%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-tert-butylbenzenesulfonamide-d2
1089215-18-8

4-tert-butylbenzenesulfonamide-d2

Conditions
ConditionsYield
With water-d2 In diethyl ether96%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

benzaldehyde
100-52-7

benzaldehyde

N-benzylidene-4-(tert-butyl)benzenesulfonamide

N-benzylidene-4-(tert-butyl)benzenesulfonamide

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In benzene for 12h; Reflux;95%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
150728-13-5

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine

4-(tert-butyl)-N-(6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidine)-4-yl)benzenesulfonamide sodium salt

4-(tert-butyl)-N-(6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidine)-4-yl)benzenesulfonamide sodium salt

Conditions
ConditionsYield
With sodium carbonate In dimethyl sulfoxide at 70 - 80℃; for 10h; Reagent/catalyst; Solvent; Temperature;95%
1-phenylpyrrolidin-2-one
4641-57-0

1-phenylpyrrolidin-2-one

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

(E)-4-(tert-butyl)-N-(1-phenylpyrrolidin-2-ylidene)benzenesulfonamide

(E)-4-(tert-butyl)-N-(1-phenylpyrrolidin-2-ylidene)benzenesulfonamide

Conditions
ConditionsYield
With diazoacetic acid ethyl ester; zinc trifluoromethanesulfonate In cyclohexane for 12h; Reflux; stereoselective reaction;94%
N-methylcyclohexylamine
626-67-5

N-methylcyclohexylamine

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-(tert-butyl)-N-(piperidin-1-ylmethylene)benzenesulfonamide

4-(tert-butyl)-N-(piperidin-1-ylmethylene)benzenesulfonamide

Conditions
ConditionsYield
With tetra-(n-butyl)ammonium iodide In ethanol at 20℃; for 12h; Electrochemical reaction; Inert atmosphere; regioselective reaction;94%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-methylphenylboronic acid
5720-05-8

4-methylphenylboronic acid

benzaldehyde
100-52-7

benzaldehyde

(R)-4-(tert-butyl)-N-(phenyl(p-tolyl)methyl)benzenesulfonamide

(R)-4-(tert-butyl)-N-(phenyl(p-tolyl)methyl)benzenesulfonamide

Conditions
ConditionsYield
With palladium(II) trifluoroacetate; (S,S)-4,4′-diisopropyl-4,5,4′,5′-tetrahydro[2.2]bioxazolyl In nitromethane at 40℃; for 64h; enantioselective reaction;93%
2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester
1160515-46-7

2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

2-[6-(4-tert-butyl-benzenesulfonylamino)-5-(2-methoxy-phenoxy)-[2,2']bipyrimidinyl-4-yloxy]-ethanol acetyl ester
1160515-53-6

2-[6-(4-tert-butyl-benzenesulfonylamino)-5-(2-methoxy-phenoxy)-[2,2']bipyrimidinyl-4-yloxy]-ethanol acetyl ester

Conditions
ConditionsYield
Stage #1: 4-tert-butylbenzenesulphonamide With potassium phosphate In N,N-dimethyl acetamide at 75 - 80℃; for 0.5h;
Stage #2: 2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester In N,N-dimethyl acetamide at 65 - 70℃; for 96h; Product distribution / selectivity;
92%
Stage #1: 4-tert-butylbenzenesulphonamide With potassium carbonate In N,N-dimethyl acetamide; acetonitrile at 75 - 80℃; for 0.5h;
Stage #2: 2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester In N,N-dimethyl acetamide; acetonitrile at 65 - 70℃; for 96h; Product distribution / selectivity;
75%
Stage #1: 4-tert-butylbenzenesulphonamide With potassium carbonate In dimethyl sulfoxide at 75 - 80℃; for 0.5h;
Stage #2: 2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester In dimethyl sulfoxide at 65 - 70℃; for 96h; Product distribution / selectivity;
60%
Stage #1: 4-tert-butylbenzenesulphonamide With potassium phosphate In N,N-dimethyl acetamide at 75 - 80℃; for 0.5h;
Stage #2: 2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester In ISOPROPYLAMIDE at 65 - 70℃; for 96h; Product distribution / selectivity;
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

acetonitrile
75-05-8

acetonitrile

diethyl 2,2'-((1-(((4-(tert-butyl)phenyl)sulfonyl)imino)ethyl)azanediyl)(E)-diacetate

diethyl 2,2'-((1-(((4-(tert-butyl)phenyl)sulfonyl)imino)ethyl)azanediyl)(E)-diacetate

Conditions
ConditionsYield
With copper(II) bis(trifluoromethanesulfonate) at 80℃; for 2h;92%
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

acetonitrile
75-05-8

acetonitrile

C20H30N2O6S

C20H30N2O6S

Conditions
ConditionsYield
With copper(II) bis(trifluoromethanesulfonate) at 80℃; for 2h;92%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

(E)-N'-(4-tert-butylphenylsulfonyl)-N,N-dimethylformimidamide

(E)-N'-(4-tert-butylphenylsulfonyl)-N,N-dimethylformimidamide

Conditions
ConditionsYield
With thionyl chloride In chloroform at 60℃; for 3h;91%
8-methylquinoline
611-32-5

8-methylquinoline

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-(tert-butyl)-N-(quinolin-8-ylmethyl)benzenesulfonamide

4-(tert-butyl)-N-(quinolin-8-ylmethyl)benzenesulfonamide

Conditions
ConditionsYield
With silver hexafluoroantimonate; dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer; [bis(acetoxy)iodo]benzene; sodium acetate In dichloromethane at 20℃; for 48h; Inert atmosphere; Schlenk technique;89%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

C34H62O6Si

C34H62O6Si

C44H75NO7SSi

C44H75NO7SSi

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 20℃; for 3h;87%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

C36H68O4Si2

C36H68O4Si2

C46H81NO5SSi2

C46H81NO5SSi2

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 20℃; for 3h;87%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

p-chlorphenylisocyanate
104-12-1

p-chlorphenylisocyanate

C17H19ClN2O3S
128924-62-9

C17H19ClN2O3S

Conditions
ConditionsYield
With sodium hydroxide In acetone86%
(4,4'-di-tert-butyl-2,2'-bipyridine)bis(trifluoromethanesulfonate)platinum(II)
177593-36-1

(4,4'-di-tert-butyl-2,2'-bipyridine)bis(trifluoromethanesulfonate)platinum(II)

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

lithium tetrakis(pentafluorophenyl)borate
2797-28-6

lithium tetrakis(pentafluorophenyl)borate

[(t-Bu2-2,2'-bipyridyl)Pt(μ-NHSO2C6H4Bu-t)]2[B(C6F5)4]2

[(t-Bu2-2,2'-bipyridyl)Pt(μ-NHSO2C6H4Bu-t)]2[B(C6F5)4]2

Conditions
ConditionsYield
In dichloromethane under inert atm. to Pt complex soln. ligand and excess Li(B(C6F5)4) in CH2Cl2 was added, mixt. was stirred at room temp. for 1 h; mixt. was filtered, evapd., solid was washed 3 times with ether, dried under vac. for 4 h; elem. anal.;86%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

cyclohexanone
108-94-1

cyclohexanone

4-(tert-butyl)-N-phenylbenzenesulfonamide

4-(tert-butyl)-N-phenylbenzenesulfonamide

Conditions
ConditionsYield
With 1,10-Phenanthroline; palladium(II) trifluoroacetate; oxygen In toluene at 140℃; for 40h;86%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4,6-dichloro-5-(2-methoxyphenyl)thiopyrimidine
374600-17-6

4,6-dichloro-5-(2-methoxyphenyl)thiopyrimidine

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenyl)thio-4-pyrimidinyl)benzenesulfonamide
167403-91-0

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenyl)thio-4-pyrimidinyl)benzenesulfonamide

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 80℃; for 1h;85%
morpholine
110-91-8

morpholine

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

(E)-4-(tert-butyl)-N-(morpholinomethylene)benzenesulfonamide

(E)-4-(tert-butyl)-N-(morpholinomethylene)benzenesulfonamide

Conditions
ConditionsYield
With copper(I) bromide In dimethyl sulfoxide at 100℃; for 24h; Schlenk technique; stereoselective reaction;85%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

(Z)-1-{2-[4-(tert-butyl)phenylsulfonamido]phenyl}-2-phenyldiazene oxide

(Z)-1-{2-[4-(tert-butyl)phenylsulfonamido]phenyl}-2-phenyldiazene oxide

Conditions
ConditionsYield
With silver hexafluoroantimonate; dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer; [bis(acetoxy)iodo]benzene In 1,2-dichloro-ethane at 80℃; for 16h; regioselective reaction;84%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-(tert-butyl)benzene-1-sulfonyl fluoride

4-(tert-butyl)benzene-1-sulfonyl fluoride

Conditions
ConditionsYield
With potassium fluoride; pyrylium tetrafluoroborate; magnesium chloride In acetonitrile at 60℃; for 2h;84%

6292-59-7Relevant articles and documents

Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds

Pallesen, Jakob S.,Narayanan, Dilip,Tran, Kim T.,Solbak, Sara M. ?.,Marseglia, Giuseppe,S?rensen, Louis M. E.,H?j, Lars J.,Munafò, Federico,Carmona, Rosa M. C.,Garcia, Anthony D.,Desu, Haritha L.,Brambilla, Roberta,Johansen, Tommy N.,Popowicz, Grzegorz M.,Sattler, Michael,Gajhede, Michael,Bach, Anders

supporting information, p. 4623 - 4661 (2021/05/07)

Targeting the protein-protein interaction (PPI) between nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (Keap1) is a potential therapeutic strategy to control diseases involving oxidative stress. Here, six classes of known small-molecule Keap1-Nrf2 PPI inhibitors were dissected into 77 fragments in a fragment-based deconstruction reconstruction (FBDR) study and tested in four orthogonal assays. This gave 17 fragment hits of which six were shown by X-ray crystallography to bind in the Keap1 Kelch binding pocket. Two hits were merged into compound 8 with a 220-380-fold stronger affinity (Ki = 16 μM) relative to the parent fragments. Systematic optimization resulted in several novel analogues with Ki values of 0.04-0.5 μM, binding modes determined by X-ray crystallography, and enhanced microsomal stability. This demonstrates how FBDR can be used to find new fragment hits, elucidate important ligand-protein interactions, and identify new potent inhibitors of the Keap1-Nrf2 PPI.

Nickel complexes with phosphines and N-R-sulfonyldithiocarbimates ligands: New antifungals for the control of Hemileia vastatrix and Phakopsora pachyrhizi

Vidigal, Antonio E.C.,Rubinger, Mayura M.M.,de Queiroz, Luan F.,da Silva, Lucas F.,Zambolim, Laércio,Guilardi, Silvana,Souza, Rafael A.C.,Ellena, Javier,Wetler, Emiliana B.,Oliveira, Marcelo R.L.

, p. 724 - 732 (2018/12/11)

Nickel(II) complexes of general formula [Ni(RSO2N = CS2)(PPh3)2] (2a–h) or [Ni(RSO2N = CS2)dppe] (3a–h), where R = methyl (a), ethyl (b), butyl (c), octyl (d), phenyl (e), 4-isopropylphenyl (f), 4-tert-butylphenyl (g), 2-naphthyl (h), PPh3 = triphenylphosphine and dppe = 1,2-bis(diphenylphosphine)ethane were prepared, from which six are new substances (2f–h and 3f–h). The new compounds were characterized by elemental analysis of C, H, N and Ni, and by IR, UV–Vis and 1H, 13C and 31P NMR spectroscopies. The data were consistent with the formation of square planar nickel(II) complexes with mixed ligands, what was confirmed by single crystal X-ray diffraction studies on compounds 2f and 2h. These complexes present intramolecular Ni–H–C anagostic interactions. All complexes inhibited the germination of Hemileia vastatrix and Phakopsora pachyrhizi, the causal agents of devastating diseases on soybean and coffee cultures. The most active compounds presented IC90 values as low as 405 μM against H. vastatrix, and 280 μM against P. pachyrhizi. Thus, the title compounds are target molecules for the development of new agrochemicals against the Asian soybean rust and Coffee leaf-rust diseases.

Design, synthesis and biological evaluation of novel phenylsulfonylurea derivatives as PI3K/mTOR dual inhibitors

Zhao, Bingbing,Lei, Fei,Wang, Caolin,Zhang, Binliang,Yang, Zunhua,Li, Wei,Zhu, Wufu,Xu, Shan

, (2018/07/13)

Five series of novel phenylsulfonylurea derivatives, 19a–d, 20a–d, 21a–d, 22a–d and 23a–d, bearing 4-phenylaminoquinoline scaffold were designed, synthesized and their IC50 values against four cancer cell lines (HepG-2, A549, PC-3 and MCF-7) were evaluated. Most compounds showed moderate cytotoxicity activity against the cancer cell lines. Structure–activity relationships (SARs) and pharmacological results indicated that introduction of 4-aminoquinoline scaffold and phenylsulfonylurea scaffold were beneficial for anti-tumor activity. Moreover, para-methoxyl substitution of 4-anilino moiety and para-halogen substitution of phenylsulfonylurea have different impacts on different series of compounds. Furthermore, the micromolecule group substitution in the 6-position of the quinoline ring have a slight impact on the cellular activity of the target compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6292-59-7